CIDP treatment: IVIg

Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .

CIDP treatment: IVIg. This is usually used as second line treatment after steroids. Fully referenced neurology checklist.

Benefits

  • This is usually used as second line treatment after steroids
  • It has a similar benefit as plasma exchange (PE)
  • It is effective in 50% of steroid non-responders

Indications for first line use of IVIg: ahead of steroids

Locked: subscribe to see this section.

Protocol

Locked: subscribe to see this section.

Response

Locked: subscribe to see this section.

Predictors of poor response

Locked: subscribe to see this section.

Predictors of good response

Locked: subscribe to see this section.

Subcutaneous immunoglobulins (SCIG)

Locked: subscribe to see this section.

Maintenance therapy

Locked: subscribe to see this section.

Treatment related fluctuations (TRFs)

Locked: subscribe to see this section.

IVIg withdrawal

Locked: subscribe to see this section.

Acronym

Locked: subscribe to see this section.

References

  1. Ripellino P, Fleetwood T, Cantello R, Comi C. Treatment of chronic inflammatory demyelinating polyneuropathy: from molecular bases to practical considerations. Autoimmune Dis 2014; 2014:201657.
  2. Eftimov F, Vermeulen M, van Doorn PA, et al. Long-term remission of CIDP after pulsed dexamethasone or short-term prednisone treatment. Neurology 2012; 78:1079-1084.
  3. van Schaik IN, Eftimov F, van Doorn PA, et al. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. Lancet Neurol 2010; 9:245-253.
  4. Kuitwaard K, Hahn AF, Vermeulen M, Venance SL, van Doorn PA. Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy. JNNP 2015; 86:1331-1336.
  5. Lehmann HC, Burke D, Kuwabara S. Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment. JNNP 2019; 90:981-987.
  6. And 19 more. Subscribe to see the full list

Related checklists

Loading...